P-528 A phase IIstudy of weeklyirinitecan (CPT-11)plus cisplatin (CDDP)in previouslyuntreated patientswith advancednon-small cell lungcancer (NSCLC) Yoichi NakanishiKiyoshi NinomiyaMasayuki Kawasaki2003 год

P-528 A phase II study of weekly irinitecan (CPT-11) plus cisplatin (CDDP) in previously untreated patients with advanced non-small cell lung cancer (NSCLC)
статья из журнала